To ask the Scottish Government on what date it expects to publish statistics from NHS boards regarding the use of Peer Approved Clinical System (PACS) Tier Two for access to the cystic fibrosis drug, Orkambi, as part of the review of the new process undertaken by the Scottish Medicines Consortium. I refer the member to the answer to question S5W-19618 on 2...